Expanded activated NK cell therapy(National University Hospital)

N/A

Report date: 2024/11/08 20:00:30

Base Information

Drug NameExpanded activated NK cell therapy(National University Hospital)

Drug Alias NameExpanded Activated Haploidentical Natural Killer Cell Therapy

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapyCell and gene therapy > Cell therapy > Donor > Allogeneic

Mechanisms of ActionImmunostimulantsNatural killer cell replacements

TargetsNot applicable

Therapy Area/IndicationsRhabdomyosarcomaSarcoma, Ewing

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySingapore

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNational University Hospital (Singapore)

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNational University Hospital (Singapore)

Active IndicationsN/A

Inactive IndicationsRhabdomyosarcomaSarcoma, Ewing

Other Information

ATC CodeN/A